カテゴリー： QYResearch, 世界

世界の女性用避妊薬市場 2019年

【英語タイトル】Global Female Contraception Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X07649）・商品コード：DATA909X07649
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：106
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、女性用避妊薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、AG-890、アンフォラ、BAY-1007626、ドロスピレノン、その他に、用途別には、クリニック、病院、在宅ケアにセグメント区分し、女性用避妊薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・女性用避妊薬の世界市場概要
・女性用避妊薬の製造コスト構成分析
・女性用避妊薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・女性用避妊薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・女性用避妊薬のセグメント分析（種類別）
（AG-890、アンフォラ、BAY-1007626、ドロスピレノン、その他）
・女性用避妊薬のセグメント分析（用途別）
（クリニック、病院、在宅ケア）
・女性用避妊薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Addex Therapeutics Ltd、Agile Therapeutics Inc、Bayer AG、Evofem Inc、Hervana Ltd、Mithra Pharmaceuticals SA、Orbis Biosciences Inc、Teva Pharmaceutical Industries Ltd、Viramal Ltd、）
・女性用避妊薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Female Contraception Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Female Contraception Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Female Contraception Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Female Contraception Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Female Contraception Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Addex Therapeutics Ltd
Agile Therapeutics Inc
Bayer AG
Evofem Inc
Hervana Ltd
Mithra Pharmaceuticals SA
Orbis Biosciences Inc
Teva Pharmaceutical Industries Ltd
Viramal Ltd

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
AG-890
Amphora
BAY-1007626
Drospirenone
Others

Segment by Application
Clinic
Hospital
Homecare

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Female Contraception Drug
1.1 Definition of Female Contraception Drug
1.2 Female Contraception Drug Segment by Type
1.2.1 Global Female Contraception Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 AG-890
1.2.3 Amphora
1.2.4 BAY-1007626
1.2.5 Drospirenone
1.2.6 Others
1.3 Female Contraception Drug Segment by Applications
1.3.1 Global Female Contraception Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Global Female Contraception Drug Overall Market
1.4.1 Global Female Contraception Drug Revenue (2014-2025)
1.4.2 Global Female Contraception Drug Production (2014-2025)
1.4.3 North America Female Contraception Drug Status and Prospect (2014-2025)
1.4.4 Europe Female Contraception Drug Status and Prospect (2014-2025)
1.4.5 China Female Contraception Drug Status and Prospect (2014-2025)
1.4.6 Japan Female Contraception Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Female Contraception Drug Status and Prospect (2014-2025)
1.4.8 India Female Contraception Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Female Contraception Drug
2.3 Manufacturing Process Analysis of Female Contraception Drug
2.4 Industry Chain Structure of Female Contraception Drug

3 Development and Manufacturing Plants Analysis of Female Contraception Drug
3.1 Capacity and Commercial Production Date
3.2 Global Female Contraception Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Female Contraception Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Female Contraception Drug Production and Capacity Analysis
4.2 Female Contraception Drug Revenue Analysis
4.3 Female Contraception Drug Price Analysis
4.4 Market Concentration Degree

5 Female Contraception Drug Regional Market Analysis
5.1 Female Contraception Drug Production by Regions
5.1.1 Global Female Contraception Drug Production by Regions
5.1.2 Global Female Contraception Drug Revenue by Regions
5.2 Female Contraception Drug Consumption by Regions
5.3 North America Female Contraception Drug Market Analysis
5.3.1 North America Female Contraception Drug Production
5.3.2 North America Female Contraception Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Female Contraception Drug Import and Export
5.4 Europe Female Contraception Drug Market Analysis
5.4.1 Europe Female Contraception Drug Production
5.4.2 Europe Female Contraception Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Female Contraception Drug Import and Export
5.5 China Female Contraception Drug Market Analysis
5.5.1 China Female Contraception Drug Production
5.5.2 China Female Contraception Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Female Contraception Drug Import and Export
5.6 Japan Female Contraception Drug Market Analysis
5.6.1 Japan Female Contraception Drug Production
5.6.2 Japan Female Contraception Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Female Contraception Drug Import and Export
5.7 Southeast Asia Female Contraception Drug Market Analysis
5.7.1 Southeast Asia Female Contraception Drug Production
5.7.2 Southeast Asia Female Contraception Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Female Contraception Drug Import and Export
5.8 India Female Contraception Drug Market Analysis
5.8.1 India Female Contraception Drug Production
5.8.2 India Female Contraception Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Female Contraception Drug Import and Export

6 Female Contraception Drug Segment Market Analysis (by Type)
6.1 Global Female Contraception Drug Production by Type
6.2 Global Female Contraception Drug Revenue by Type
6.3 Female Contraception Drug Price by Type

7 Female Contraception Drug Segment Market Analysis (by Application)
7.1 Global Female Contraception Drug Consumption by Application
7.2 Global Female Contraception Drug Consumption Market Share by Application (2014-2019)

8 Female Contraception Drug Major Manufacturers Analysis
8.1 Addex Therapeutics Ltd
8.1.1 Addex Therapeutics Ltd Female Contraception Drug Production Sites and Area Served
8.1.2 Addex Therapeutics Ltd Product Introduction, Application and Specification
8.1.3 Addex Therapeutics Ltd Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Agile Therapeutics Inc
8.2.1 Agile Therapeutics Inc Female Contraception Drug Production Sites and Area Served
8.2.2 Agile Therapeutics Inc Product Introduction, Application and Specification
8.2.3 Agile Therapeutics Inc Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Bayer AG
8.3.1 Bayer AG Female Contraception Drug Production Sites and Area Served
8.3.2 Bayer AG Product Introduction, Application and Specification
8.3.3 Bayer AG Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Evofem Inc
8.4.1 Evofem Inc Female Contraception Drug Production Sites and Area Served
8.4.2 Evofem Inc Product Introduction, Application and Specification
8.4.3 Evofem Inc Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Hervana Ltd
8.5.1 Hervana Ltd Female Contraception Drug Production Sites and Area Served
8.5.2 Hervana Ltd Product Introduction, Application and Specification
8.5.3 Hervana Ltd Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Mithra Pharmaceuticals SA
8.6.1 Mithra Pharmaceuticals SA Female Contraception Drug Production Sites and Area Served
8.6.2 Mithra Pharmaceuticals SA Product Introduction, Application and Specification
8.6.3 Mithra Pharmaceuticals SA Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Orbis Biosciences Inc
8.7.1 Orbis Biosciences Inc Female Contraception Drug Production Sites and Area Served
8.7.2 Orbis Biosciences Inc Product Introduction, Application and Specification
8.7.3 Orbis Biosciences Inc Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Teva Pharmaceutical Industries Ltd
8.8.1 Teva Pharmaceutical Industries Ltd Female Contraception Drug Production Sites and Area Served
8.8.2 Teva Pharmaceutical Industries Ltd Product Introduction, Application and Specification
8.8.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Viramal Ltd
8.9.1 Viramal Ltd Female Contraception Drug Production Sites and Area Served
8.9.2 Viramal Ltd Product Introduction, Application and Specification
8.9.3 Viramal Ltd Female Contraception Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served

9 Development Trend of Analysis of Female Contraception Drug Market
9.1 Global Female Contraception Drug Market Trend Analysis
9.1.1 Global Female Contraception Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Female Contraception Drug Regional Market Trend
9.2.1 North America Female Contraception Drug Forecast 2019-2025
9.2.2 Europe Female Contraception Drug Forecast 2019-2025
9.2.3 China Female Contraception Drug Forecast 2019-2025
9.2.4 Japan Female Contraception Drug Forecast 2019-2025
9.2.5 Southeast Asia Female Contraception Drug Forecast 2019-2025
9.2.6 India Female Contraception Drug Forecast 2019-2025
9.3 Female Contraception Drug Market Trend (Product Type)
9.4 Female Contraception Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Female Contraception Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Female Contraception Drug
Table Global Female Contraception Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Female Contraception Drug Production Market Share by Types in 2018
Figure AG-890 Product Picture
Figure Amphora Product Picture
Figure BAY-1007626 Product Picture
Figure Drospirenone Product Picture
Figure Others Product Picture
Table Global Female Contraception Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Female Contraception Drug Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Homecare
Figure Global Female Contraception Drug Revenue (Million USD) (2014-2025)
Figure Global Female Contraception Drug Production (K Pcs) (2014-2025)
Figure North America Female Contraception Drug Market Size (Million USD) (2014-2025)
Figure Europe Female Contraception Drug Market Size (Million USD) (2014-2025)
Figure China Female Contraception Drug Market Size (Million USD) (2014-2025)
Figure Japan Female Contraception Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Female Contraception Drug Market Size (Million USD) (2014-2025)
Figure India Female Contraception Drug Market Size (Million USD) (2014-2025)
Table Female Contraception Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Female Contraception Drug in 2018
Figure Manufacturing Process Analysis of Female Contraception Drug
Figure Industry Chain Structure of Female Contraception Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Female Contraception Drug Manufacturing Plants Distribution
Table Female Contraception Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Female Contraception Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Female Contraception Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Female Contraception Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Female Contraception Drug Production Share by Manufacturers in 2018
Table Female Contraception Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Female Contraception Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Female Contraception Drug Revenue Share by Manufacturers in 2018
Table Female Contraception Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Female Contraception Drug Production by Regions 2014-2019 (K Pcs)
Table Global Female Contraception Drug Production Market Share by Regions 2014-2019
Figure Global Female Contraception Drug Production Market Share by Regions in 2018
Table Global Female Contraception Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Female Contraception Drug Revenue Market Share by Regions 2014-2019
Figure Global Female Contraception Drug Revenue Market Share by Regions in 2018
Table Global Female Contraception Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Female Contraception Drug Consumption Market Share by Regions 2014-2019
Figure North America Female Contraception Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Female Contraception Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Female Contraception Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Female Contraception Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Female Contraception Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Female Contraception Drug Production, Consumption Import and Export (K Pcs)
Figure China Female Contraception Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Female Contraception Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Female Contraception Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Female Contraception Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Female Contraception Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Female Contraception Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Female Contraception Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Female Contraception Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Female Contraception Drug Production, Consumption Import and Export (K Pcs)
Figure India Female Contraception Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Female Contraception Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Female Contraception Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Female Contraception Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Female Contraception Drug Market Share by Application (2014-2019)
Table Addex Therapeutics Ltd Female Contraception Drug Production Sites and Area Served
Table Addex Therapeutics Ltd Female Contraception Drug Product Introduction, Application and Specification
Table Addex Therapeutics Ltd Female Contraception Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Addex Therapeutics Ltd Female Contraception Drug Production Growth Rate (2014-2019)
Table Addex Therapeutics Ltd Female Contraception Drug Production Market Share (2014-2019)
Figure Addex Therapeutics Ltd Female Contraception Drug Revenue Market Share (2014-2019)
Table Addex Therapeutics Ltd Female Contraception Drug Main Business and Markets Served
Table Agile Therapeutics Inc Female Contraception Drug Production Sites and Area Served
Table Agile Therapeutics Inc Female Contraception Drug Product Introduction, Application and Specification
Table Agile Therapeutics Inc Female Contraception Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Agile Therapeutics Inc Female Contraception Drug Production Growth Rate (2014-2019)
Table Agile Therapeutics Inc Female Contraception Drug Production Market Share (2014-2019)
Figure Agile Therapeutics Inc Female Contraception Drug Revenue Market Share (2014-2019)
Table Agile Therapeutics Inc Female Contraception Drug Main Business and Markets Served
Table Bayer AG Female Contraception Drug Production Sites and Area Served
Table Bayer AG Female Contraception Drug Product Introduction, Application and Specification
Table Bayer AG Female Contraception Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bayer AG Female Contraception Drug Production Growth Rate (2014-2019)
Table Bayer AG Female Contraception Drug Production Market Share (2014-2019)
Figure Bayer AG Female Contraception Drug Revenue Market Share (2014-2019)
Table Bayer AG Female Contraception Drug Main Business and Markets Served
Table Evofem Inc Female Contraception Drug Production Sites and Area Served
Table Evofem Inc Female Contraception Drug Product Introduction, Application and Specification
Table Evofem Inc Female Contraception Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Evofem Inc Female Contraception Drug Production Growth Rate (2014-2019)
Table Evofem Inc Female Contraception Drug Production Market Share (2014-2019)
Figure Evofem Inc Female Contraception Drug Revenue Market Share (2014-2019)
Table Evofem Inc Female Contraception Drug Main Business and Markets Served
Table Hervana Ltd Female Contraception Drug Production Sites and Area Served
Table Hervana Ltd Female Contraception Drug Product Introduction, Application and Specification
Table Hervana Ltd Female Contraception Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Hervana Ltd Female Contraception Drug Production Growth Rate (2014-2019)
Table Hervana Ltd Female Contraception Drug Production Market Share (2014-2019)
Figure Hervana Ltd Female Contraception Drug Revenue Market Share (2014-2019)
Table Hervana Ltd Female Contraception Drug Main Business and Markets Served
Table Mithra Pharmaceuticals SA Female Contraception Drug Production Sites and Area Served
Table Mithra Pharmaceuticals SA Female Contraception Drug Product Introduction, Application and Specification
Table Mithra Pharmaceuticals SA Female Contraception Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Mithra Pharmaceuticals SA Female Contraception Drug Production Growth Rate (2014-2019)
Table Mithra Pharmaceuticals SA Female Contraception Drug Production Market Share (2014-2019)
Figure Mithra Pharmaceuticals SA Female Contraception Drug Revenue Market Share (2014-2019)
Table Mithra Pharmaceuticals SA Female Contraception Drug Main Business and Markets Served
Table Orbis Biosciences Inc Female Contraception Drug Production Sites and Area Served
Table Orbis Biosciences Inc Female Contraception Drug Product Introduction, Application and Specification
Table Orbis Biosciences Inc Female Contraception Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Orbis Biosciences Inc Female Contraception Drug Production Growth Rate (2014-2019)
Table Orbis Biosciences Inc Female Contraception Drug Production Market Share (2014-2019)
Figure Orbis Biosciences Inc Female Contraception Drug Revenue Market Share (2014-2019)
Table Orbis Biosciences Inc Female Contraception Drug Main Business and Markets Served
Table Teva Pharmaceutical Industries Ltd Female Contraception Drug Production Sites and Area Served
Table Teva Pharmaceutical Industries Ltd Female Contraception Drug Product Introduction, Application and Specification
Table Teva Pharmaceutical Industries Ltd Female Contraception Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Ltd Female Contraception Drug Production Growth Rate (2014-2019)
Table Teva Pharmaceutical Industries Ltd Female Contraception Drug Production Market Share (2014-2019)
Figure Teva Pharmaceutical Industries Ltd Female Contraception Drug Revenue Market Share (2014-2019)
Table Teva Pharmaceutical Industries Ltd Female Contraception Drug Main Business and Markets Served
Table Viramal Ltd Female Contraception Drug Production Sites and Area Served
Table Viramal Ltd Female Contraception Drug Product Introduction, Application and Specification
Table Viramal Ltd Female Contraception Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Viramal Ltd Female Contraception Drug Production Growth Rate (2014-2019)
Table Viramal Ltd Female Contraception Drug Production Market Share (2014-2019)
Figure Viramal Ltd Female Contraception Drug Revenue Market Share (2014-2019)
Table Viramal Ltd Female Contraception Drug Main Business and Markets Served
Figure Global Female Contraception Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Female Contraception Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Female Contraception Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Female Contraception Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Female Contraception Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Female Contraception Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Female Contraception Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Female Contraception Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Female Contraception Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Female Contraception Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Female Contraception Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Female Contraception Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Female Contraception Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Female Contraception Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Female Contraception Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Female Contraception Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Female Contraception Drug by Application (2019-2025)
Table Female Contraception Drug Distributors List
Table Female Contraception Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Addex Therapeutics Ltd、Agile Therapeutics Inc、Bayer AG、Evofem Inc、Hervana Ltd、Mithra Pharmaceuticals SA、Orbis Biosciences Inc、Teva Pharmaceutical Industries Ltd、Viramal Ltd、

★調査レポート[世界の女性用避妊薬市場 2019年] (コード：DATA909X07649)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の女性用避妊薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の女性用性的欲求低下障害治療市場 2019年
    DATA909X07650 / QYResearch / 2019年11月15日 / ※本調査レポートは、女性用性的欲求低下障害治療の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BP-101、ブレメラノチド、ゲピロン塩酸塩ER、PVT-011、その他に、用途別には、外来患者、入院患者にセグメント区分し、女性用性的欲求低下障害治療の世界市場を分析しました。 ・エグゼクティブ・サマリー ・女性用性的欲求低下障害治療の世界市場概要 ・女性用性的欲求低下障害治療の製造コスト構成分析 ・女性用性的欲求低下障害治療の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・女性用性的欲求低下障害治療の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・女性用性的欲求低下障害治療のセグメント分析（種類別） （BP-101、ブレメラノチド、ゲピロン塩酸塩ER、PVT-011、その他）...The global Female Hypoactive Sexual Desire Disorder Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Female Hypoactive Sexual Desire Disorder Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Female Hypoactive Sexual Desire Disorder Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Female Hypoactive Sexual Desire Disorder Therapeutics in North America, Europe, China,...
  • 世界のタミフル（オセルタミビル）薬市場 2019年
    DATA909X16262 / QYResearch / 2019年11月22日 / ※本調査レポートは、タミフル（オセルタミビル）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カプセル、経口液に、用途別には、インフルエンザA、インフルエンザBにセグメント区分し、タミフル（オセルタミビル）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・タミフル（オセルタミビル）薬の世界市場概要 ・タミフル（オセルタミビル）薬の製造コスト構成分析 ・タミフル（オセルタミビル）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・タミフル（オセルタミビル）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・タミフル（オセルタミビル）薬のセグメント分析（種類別） （カプセル、経口液）...The global Tamiflu (Oseltamivir) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tamiflu (Oseltamivir) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tamiflu (Oseltamivir) Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tamiflu (Oseltamivir) Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 女性用性機能障害治療の世界市場：規模・現状・予測2019-2025
    DATA909X18465 / QYResearch / 2019年11月25日 / ※当調査レポートでは、女性用性機能障害治療の世界市場について調査・分析し、女性用性機能障害治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（非ホルモン療法、ホルモン療法）、用途別（性的欲求障害、性的興奮障害、オルガスム障害、性的疼痛障害、オルガスム後疾患、骨盤底機能障害、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の女性用性機能障害治療市場動向 ・主要企業別マーケットシェア ・女性用性機能障害治療の種類別市場規模2014-2019 （非ホルモン療法、ホルモン療法） ・女性用性機能障害治療の用途別市場規模2014-2019 （性的欲求障害、性的興奮障害、オルガスム障害、性的疼痛障害、オルガスム後疾患、骨盤底機能障害、その他） ・女性用性機能障害治療の北米市場：主要企業・種類別/用途別市場規模 ・女性用性機能障害治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Sexual dysfunction is difficulty experienced by an individual or a couple during any stage of a normal sexual activity, including physical pleasure, desire, preference, arousal or orgasm. The increasing prevalence of chronic diseases is one of the key factors that will drive the growth of the market during the forecast period. Women suffering from chronic health conditions such as diabetes may also be diagnosed with sexual dysfunction. Clinical indications, including hypertension, obesity, metabolic syndrome, and atherogenic dyslipidemia, of chronic conditions such as diabetes, are the risk factors for sexual dysfunctions in women. The rising prevalence of chronic health conditions in...
  • 世界の甲状腺機能低下症薬市場 2019年
    DATA909X09522 / QYResearch / 2019年11月20日 / ※本調査レポートは、甲状腺機能低下症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他に、用途別には、病院、診療所、その他にセグメント区分し、甲状腺機能低下症薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・甲状腺機能低下症薬の世界市場概要 ・甲状腺機能低下症薬の製造コスト構成分析 ・甲状腺機能低下症薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・甲状腺機能低下症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・甲状腺機能低下症薬のセグメント分析（種類別） （BCT-305、GX-30、レボチロキシンナトリウムSR、リオチロニン、その他）...The global Hypothyroidism Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Hypothyroidism Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hypothyroidism Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Hypothyroidism Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Hypothyroidism Drug manufacturing...
  • 世界の女性不妊症治療薬産業：成長傾向・競合分析2019-2025
    DATA909X00868 / QYResearch / 2019年11月22日 / ※本調査レポートでは、世界の女性不妊症治療薬市場について調査・分析し、市場規模、市場動向、市場予測（～2025年）、市場シェア、関連企業情報などを含め、以下の構成でお届け致します。女性不妊症治療薬の種類別には、非経口、経口、その他に、用途別には、不妊治療クリニック、病院、クライオバンクに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査レポートの概要 ・グローバル成長傾向・産業動向 ・企業別市場シェア ・女性不妊症治療薬の種類別市場規模：非経口、経口、その他 ・女性不妊症治療薬の用途別市場規模：不妊治療クリニック、病院、クライオバンク ・女性不妊症治療薬の地域別市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ ・主要企業のプロフィール：Allergan Plc、Ferring BV、Merck...Female Infertility Drugs are usually prescribed to women as they're mostly used to help with ovulation problems.In 2018, the global Female Infertility Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2019. In this study, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Female Infertility Drugs. This study researches the market size of Female Infertility Drugs, presents the global Female Infertility Drugs sales and revenue by companies, regions, type and application, history breakdown data from...
  • 世界のコクシジオイデス症薬剤市場 2019年
    DATA909X05597 / QYResearch / 2019年11月15日 / ※本調査レポートは、コクシジオイデス症薬剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他に、用途別には、クリニック、病院、その他にセグメント区分し、コクシジオイデス症薬剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・コクシジオイデス症薬剤の世界市場概要 ・コクシジオイデス症薬剤の製造コスト構成分析 ・コクシジオイデス症薬剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・コクシジオイデス症薬剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・コクシジオイデス症薬剤のセグメント分析（種類別） （VT-1161、APX-001、VT-1598、ニッコマイシンZ、その他）...The global Coccidioidomycosis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Coccidioidomycosis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Coccidioidomycosis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Coccidioidomycosis Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Coccidioidomycosis Drug manufacturing...

    • ◆H&Iグローバルリサーチのお客様（例）◆